Your browser doesn't support javascript.
loading
Could prophylactic antivirals reduce dengue incidence in a high-prevalence endemic area?
Jafari, Yalda; Brady, Oliver J; Biggs, Joseph R; Lien, Le Thuy; Mai, Huynh Kim; Nguyen, Hien Anh Thi; Van Loock, Marnix; Herrera-Taracena, Guillermo; Menten, Joris; Iwasaki, Chihiro; Takegata, Mizuki; Kitamura, Noriko; Do Thai, Hung; Minh, Bui Xuan; Morita, Kouichi; Anh, Dang Duc; Clifford, Sam; Prem, Kiesha; Hafalla, Julius; Edmunds, W John; Yoshida, Lay Myint; Hibberd, Martin L; Hué, Stéphane.
Affiliation
  • Jafari Y; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Brady OJ; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Biggs JR; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Lien LT; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Mai HK; Department of Infection Biology, Faculty of Infectious Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Nguyen HAT; Pasteur Institute in Nha Trang, Nha Trang, Vietnam.
  • Van Loock M; Pasteur Institute in Nha Trang, Nha Trang, Vietnam.
  • Herrera-Taracena G; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Menten J; Janssen Research & Development, Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
  • Iwasaki C; Janssen Research & Development, Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
  • Takegata M; Janssen Research & Development, Janssen Pharmaceutica NV, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.
  • Kitamura N; Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
  • Do Thai H; Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
  • Minh BX; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Morita K; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Anh DD; Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
  • Clifford S; Pasteur Institute in Nha Trang, Nha Trang, Vietnam.
  • Prem K; Khanh Hoa health Service Department, Nha Trang, Vietnam.
  • Hafalla J; Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
  • Edmunds WJ; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Yoshida LM; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Hibberd ML; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Hué S; Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
PLoS Negl Trop Dis ; 18(7): e0012334, 2024 Jul.
Article in En | MEDLINE | ID: mdl-39074158
ABSTRACT
Prophylactic drugs against dengue are currently under development. In this study, we explored how such prophylactic approaches might affect dengue cases in four communes of Nha Trang City, Vietnam. A community level dengue transmission survey indicated high levels of previous exposure to dengue (89.7%; 95% CI 87.2,92.0). We fitted a spatially explicit model to an observed outbreak and simulated likely effectiveness of Case-Area Targeted Interventions (CATI) and One-Time Mass Distribution (OTMD) of drug and vector control strategies. Increasing radius and effectiveness and decreasing delay of CATI was most effective, with drugs being more effective in averting dengue cases than vector control. Using an OTMD approach early in the outbreak required the least number of treatments to avert a case, suggesting that OTMD strategies should be considered as pre-emptive rather than reactive strategies. These findings show that pre-emptive interventions can substantially reduce the burden of dengue outbreaks in endemic settings.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Dengue Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: PLoS Negl Trop Dis Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Dengue Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: PLoS Negl Trop Dis Year: 2024 Document type: Article